North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research
about
The empirical status of the ultra high-risk (prodromal) research paradigmRealistic expectations of prepulse inhibition in translational models for schizophrenia research.Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndromeWorking with Asian American youth at clinical high risk for psychosis: a case illustrationStress and neurodevelopmental processes in the emergence of psychosisHow can studies of resting-state functional connectivity help us understand psychosis as a disorder of brain development?Developmental mechanisms in the prodrome to psychosisNorth American Prodrome Longitudinal Study (NAPLS 2): The Prodromal SymptomsCharacterization of neurophysiologic and neurocognitive biomarkers for use in genomic and clinical outcome studies of schizophreniaEarly Recognition of High Risk of Bipolar Disorder and Psychosis: An Overview of the ZInEP "Early Recognition" Study.Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population.Emotion processing in persons at risk for schizophrenia.Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011Reliability of an fMRI paradigm for emotional processing in a multisite longitudinal study.Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies.How frequent is chronic multiyear delusional activity and recovery in schizophrenia: a 20-year multi-follow-upGlycine treatment of the risk syndrome for psychosis: report of two pilot studiesThe development of psychotic disorders in adolescence: a potential role for hormonesYouth-caregiver agreement on clinical high-risk symptoms of psychosis.Prevention and treatment of long-term social disability amongst young people with emerging severe mental illness with social recovery therapy (The PRODIGY Trial): study protocol for a randomised controlled trialRecent advances in understanding schizophreniaFamily-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trialNegative symptoms in individuals at clinical high risk of psychosis.The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis.Correspondence between psychometric and clinical high risk for psychosis in an undergraduate population.Current status specifiers for patients at clinical high risk for psychosis.Practitioner review: schizophrenia spectrum disorders and the at-risk mental state for psychosis in children and adolescents--evidence-based management approaches.Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North AmericaAre screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview.The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome."Attenuated psychotic symptoms syndrome" as a risk syndrome of psychosis, diagnosis in DSM-V: The debateTreatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study CohortPrevention of the first episode of psychosis.Strategies for effective recruitment of individuals at risk for developing psychosisAt clinical high risk for psychosis: outcome for nonconverters.Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activationRecruitment strategies for the detection of individuals at clinical high risk of developing psychosisPremorbid functional development and conversion to psychosis in clinical high-risk youths.Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
P2860
Q22242833-2396C87D-CA3B-436E-885E-5A6AFD116F62Q24645703-C2B41656-DBB1-4B8B-90B7-B94C862F145BQ26824150-984BDF09-4C6D-4DFB-9BF0-8E0C1A5D2F16Q26827530-004E7F0D-4CD7-4DCF-9035-9122FEAAE8E8Q26830600-7EA28246-1C28-482A-AE39-E3B26539D2A4Q27008055-92239162-7D50-4E2C-89C2-8D3A0DE32657Q27009237-07E2D66C-4A95-4489-A4E6-5BC4414A0CF1Q27011767-E03F1AC6-D4D2-4D70-92E5-E8012FD3FD05Q28727584-A4C39B48-5212-4154-8431-A54636CDCF5EQ30390500-48B1F68A-CB48-41FF-ABA0-7CBD438C53CBQ30465425-D45A3688-AB02-4DDA-8B08-CA5BB432699EQ30487300-AD569A5D-2443-46B3-BB93-903DFD399E85Q30650589-D340C9C0-484B-4AA1-BDCE-CC8D051794BCQ30655449-43CF6500-6DC7-450E-AC83-98C877B70F9DQ31120585-416EEB6B-9805-4374-94FC-38FDB77062DBQ33566091-435F745B-1C19-4E9E-A8EE-ACE3B323C930Q33637911-58A8677F-AE46-41D0-8EE1-9142A167EA67Q33806650-FC8C7B19-4EE9-4FF5-B8BD-3BA924F6EEBFQ33820520-E9BF3B1B-AEC6-42AD-BE32-8B6CB88D1030Q33892036-85501128-6B91-42CC-88E9-B946867A53CBQ33942094-D440AE9A-993D-4850-8E0A-9A257111E740Q33954717-857D5AC9-F512-426C-BCEC-410AE4AF51BBQ33992721-F45F2D81-D8F2-42A4-BA34-2907D5885F22Q34071212-1A4A3498-F6A9-4499-8F52-F5EC8EB79F78Q34122956-97FAAFEB-12DC-446B-9FBB-BCE01AFFD78FQ34123531-D7C4336F-8D12-405B-A4AB-29B88ACD17D1Q34376032-9DDBD8D2-7E2C-43D7-9CA1-E95AB7AD2530Q34501767-9ECA891F-4A40-42D3-8B6D-39D710F2B08CQ34586836-B6DB6610-295C-4527-8EE7-0FFE7A360B9AQ34604254-71884FC5-CC33-4891-B93C-F5C6C892D586Q34623331-A8B8182C-B46E-4991-95D8-90C4BCA333BBQ34664735-855B7B31-A134-4B32-A517-353927E7AEA8Q34727780-1370DFF0-DB7E-4ACC-9001-FDD4B4C3DE40Q34776827-A6938D41-77E4-4396-AEEA-41E41F317DCBQ35132114-35FE34E0-4FF0-4C1E-966D-196B1D950315Q35148454-129BBC11-E96C-4CEC-BB3F-A7121288B73FQ35166842-8401A657-1881-47B6-878C-F5062BEB6DA9Q35168094-E9574EA1-5A09-408A-83D9-701AD413C439Q35168098-CF7E5190-64C3-40C0-903C-36CC5356BF0EQ35185253-6592F49C-6223-41D4-AE27-8B3D44CDAB7F
P2860
North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
North American Prodrome Longit ...... odromal schizophrenia research
@ast
North American Prodrome Longit ...... odromal schizophrenia research
@en
North American Prodrome Longit ...... odromal schizophrenia research
@en-gb
North American Prodrome Longit ...... odromal schizophrenia research
@nl
type
label
North American Prodrome Longit ...... odromal schizophrenia research
@ast
North American Prodrome Longit ...... odromal schizophrenia research
@en
North American Prodrome Longit ...... odromal schizophrenia research
@en-gb
North American Prodrome Longit ...... odromal schizophrenia research
@nl
prefLabel
North American Prodrome Longit ...... odromal schizophrenia research
@ast
North American Prodrome Longit ...... odromal schizophrenia research
@en
North American Prodrome Longit ...... odromal schizophrenia research
@en-gb
North American Prodrome Longit ...... odromal schizophrenia research
@nl
P2093
P2860
P50
P356
P1476
North American Prodrome Longit ...... odromal schizophrenia research
@en
P2093
Barbara Cornblatt
Diana O Perkins
Elaine F Walker
Ming Tsuang
Robert Heinssen
Scott W Woods
P2860
P304
P356
10.1093/SCHBUL/SBL075
P407
P577
2007-05-01T00:00:00Z